IN2012DN02401A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02401A
IN2012DN02401A IN2401DEN2012A IN2012DN02401A IN 2012DN02401 A IN2012DN02401 A IN 2012DN02401A IN 2401DEN2012 A IN2401DEN2012 A IN 2401DEN2012A IN 2012DN02401 A IN2012DN02401 A IN 2012DN02401A
Authority
IN
India
Prior art keywords
mutated
gene
tsp
protein
ptr
Prior art date
Application number
Other languages
English (en)
Inventor
Mark Ellis
David Paul Humphreys
Original Assignee
Ucb Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0916822.0A external-priority patent/GB0916822D0/en
Priority claimed from GB0916821A external-priority patent/GB0916821D0/en
Application filed by Ucb Pharma Sa filed Critical Ucb Pharma Sa
Publication of IN2012DN02401A publication Critical patent/IN2012DN02401A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241Tumor Necrosis Factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244Interleukins [IL]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55Fab or Fab'
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185Escherichia
    • C12R2001/19Escherichia coli
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
IN2401DEN2012 2009-09-24 2010-09-23 IN2012DN02401A (OSRAM)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0916822.0A GB0916822D0 (en) 2009-09-24 2009-09-24 Bacterial host strain
GB0916821A GB0916821D0 (en) 2009-09-24 2009-09-24 Bacterial host strain
PCT/GB2010/001790 WO2011036454A1 (en) 2009-09-24 2010-09-23 Bacterial host strain

Publications (1)

Publication Number Publication Date
IN2012DN02401A true IN2012DN02401A (OSRAM) 2015-08-21

Family

ID=43003459

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2401DEN2012 IN2012DN02401A (OSRAM) 2009-09-24 2010-09-23

Country Status (21)

Country Link
US (3) US9109216B2 (OSRAM)
EP (2) EP2480661A1 (OSRAM)
JP (2) JP6132551B2 (OSRAM)
KR (1) KR101758942B1 (OSRAM)
CN (1) CN102575241B (OSRAM)
AU (2) AU2010299640B2 (OSRAM)
BR (1) BR112012006670B8 (OSRAM)
CA (1) CA2774692C (OSRAM)
CY (1) CY1120947T1 (OSRAM)
DK (1) DK2993231T3 (OSRAM)
ES (1) ES2692811T3 (OSRAM)
HR (1) HRP20181482T1 (OSRAM)
HU (1) HUE040306T2 (OSRAM)
IN (1) IN2012DN02401A (OSRAM)
LT (1) LT2993231T (OSRAM)
PL (1) PL2993231T3 (OSRAM)
PT (1) PT2993231T (OSRAM)
SG (1) SG10201606462WA (OSRAM)
SI (1) SI2993231T1 (OSRAM)
SM (1) SMT201800549T1 (OSRAM)
WO (1) WO2011036454A1 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2012DN02401A (OSRAM) * 2009-09-24 2015-08-21 Ucb Pharma Sa
GB201000591D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
RS56926B1 (sr) * 2011-07-13 2018-05-31 Ucb Biopharma Sprl Bakterijski soj domaćina koji izražava rekombinantnu dsbc
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
EP4467565A3 (en) 2016-12-21 2025-03-12 Amgen Inc. Anti-tnf alpha antibody formulations
EP3774926A1 (en) 2018-04-05 2021-02-17 Bio-Rad ABD Serotec GmbH Display systems for proteins of interest
CN113874518B (zh) 2019-03-18 2025-04-25 生物辐射Abd瑟罗泰克有限公司 保护含SpyTag的周质融合蛋白免于蛋白酶Tsp和OmpT降解
CN110616181A (zh) * 2019-09-27 2019-12-27 北京理工大学 一株基于大肠杆菌改造的工程菌株
CN117965503B (zh) * 2024-02-02 2024-08-09 南京迪诺薇华生物科技有限公司 一种蛋白酶突变体及其在洗护肤品、化妆品中的应用

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508192A (en) * 1990-11-09 1996-04-16 Board Of Regents, The University Of Texas System Bacterial host strains for producing proteolytically sensitive polypeptides
US5264365A (en) 1990-11-09 1993-11-23 Board Of Regents, The University Of Texas System Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides
GB9215540D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
AU2660397A (en) 1996-04-05 1997-10-29 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
US6083715A (en) 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
JP4249832B2 (ja) * 1998-12-28 2009-04-08 タカラバイオ株式会社 トリガーファクター発現プラスミド
AU767670B2 (en) * 1999-06-29 2003-11-20 Siga Technologies, Inc. DEGP periplasmic protease a new anti-infective target and an invitro assay for DEGP protease function
GB0006398D0 (en) 2000-03-16 2000-05-03 Novartis Ag Organic compounds
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
EP1314037A2 (en) 2000-09-01 2003-05-28 Biogen, Inc. Methods of designing and producing compounds having improved binding affinity for cd154 or other trimeric proteins
AU8867501A (en) 2000-09-01 2002-03-13 Biogen Inc Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
US7041479B2 (en) 2000-09-06 2006-05-09 The Board Of Trustess Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
PL205897B1 (pl) * 2000-12-14 2010-06-30 Genentech Inc Komórka gospodarza E. coli i sposób wytwarzania polipeptydu
JP4309656B2 (ja) 2000-12-14 2009-08-05 ジェネンテック・インコーポレーテッド 原核生物で生成させた抗体とその用途
TWI334439B (en) 2001-08-01 2010-12-11 Centocor Inc Anti-tnf antibodies, compositions, methods and uses
KR100968664B1 (ko) 2001-08-27 2010-07-06 제넨테크, 인크. 항체 발현 및 조립을 위한 시스템
GB0124317D0 (en) 2001-10-10 2001-11-28 Celltech R&D Ltd Biological products
IL161988A0 (en) 2001-11-16 2005-11-20 Corporation Idec Pharmaceutica Polycistronic expression of antibodies
GB0129105D0 (en) 2001-12-05 2002-01-23 Celltech R&D Ltd Expression control using variable intergenic sequences
EP1517921B1 (en) 2002-06-28 2006-06-07 Domantis Limited Dual specific ligands with increased serum half-life
NZ538996A (en) 2002-10-31 2008-04-30 Genentech Inc Methods and compositions for increasing antibody production
CA2507004A1 (en) 2002-12-03 2004-06-17 Celltech R & D Limited Assay for identifying antibody producing cells
GB0303337D0 (en) 2003-02-13 2003-03-19 Celltech R&D Ltd Biological products
ATE482235T1 (de) 2003-06-13 2010-10-15 Biogen Idec Inc Aglycosyl-anti-cd154 (cd40-ligand) antikörper und deren verwendungen
CN1845938B (zh) 2003-06-30 2010-05-26 杜门蒂斯有限公司 多肽
GB0315450D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
GB0315457D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
NZ580688A (en) 2003-07-26 2012-03-30 Biogen Idec Inc Method of designing altered antibodies having improved antigen-binding affinity
JP5102028B2 (ja) 2004-07-26 2012-12-19 バイオジェン・アイデック・エムエイ・インコーポレイテッド 抗cd154抗体
WO2006028936A2 (en) 2004-09-02 2006-03-16 Genentech, Inc. Heteromultimeric molecules
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
GB0425534D0 (en) 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
BRPI0809042B1 (pt) 2007-03-22 2021-08-31 Biogen Ma Inc. Proteína de ligação a cd154 isolada, seu uso, e composição
WO2008126785A1 (ja) * 2007-04-06 2008-10-23 Kyowa Hakko Kirin Co., Ltd. 有用物質の製造法
US7741088B2 (en) * 2007-10-31 2010-06-22 E.I. Dupont De Nemours And Company Immobilized microbial nitrilase for production of glycolic acid
JP5217780B2 (ja) * 2008-02-08 2013-06-19 味の素株式会社 L−アミノ酸を生産する微生物及びl−アミノ酸の製造法
US7662587B1 (en) 2009-03-05 2010-02-16 E. I. Du Pont De Nemours And Company Gene knockout mutations that increase peptide production
IN2012DN02401A (OSRAM) 2009-09-24 2015-08-21 Ucb Pharma Sa
US8470552B2 (en) 2009-10-12 2013-06-25 Keck Graduate Institute Strategy to reduce lactic acid production and control PH in animal cell culture
WO2011057120A1 (en) 2009-11-05 2011-05-12 Genentech, Inc. Methods and composition for secretion of heterologous polypeptides
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000588D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000591D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
RS56926B1 (sr) 2011-07-13 2018-05-31 Ucb Biopharma Sprl Bakterijski soj domaćina koji izražava rekombinantnu dsbc
EP2546267A1 (en) 2011-07-13 2013-01-16 UCB Pharma S.A. Bacterial host strain expressing recombinant DsbC
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product

Also Published As

Publication number Publication date
US20160200810A1 (en) 2016-07-14
JP2013505714A (ja) 2013-02-21
US20150344840A1 (en) 2015-12-03
CA2774692C (en) 2017-12-19
US9109216B2 (en) 2015-08-18
CN102575241A (zh) 2012-07-11
PT2993231T (pt) 2018-11-12
SI2993231T1 (sl) 2018-10-30
KR101758942B1 (ko) 2017-07-17
EP2993231B1 (en) 2018-08-01
CY1120947T1 (el) 2019-12-11
JP6132551B2 (ja) 2017-05-24
LT2993231T (lt) 2018-11-12
SG10201606462WA (en) 2016-09-29
DK2993231T3 (en) 2018-10-22
US9550973B2 (en) 2017-01-24
US20120258492A1 (en) 2012-10-11
PL2993231T3 (pl) 2019-01-31
BR112012006670B1 (pt) 2021-08-03
CN102575241B (zh) 2016-02-24
HK1172650A1 (zh) 2013-04-26
HUE040306T2 (hu) 2019-03-28
AU2016201536A1 (en) 2016-03-24
BR112012006670B8 (pt) 2022-03-03
AU2010299640B2 (en) 2016-02-25
CA2774692A1 (en) 2011-03-31
KR20120083435A (ko) 2012-07-25
AU2010299640A1 (en) 2012-04-12
HRP20181482T1 (hr) 2018-11-02
BR112012006670A2 (pt) 2015-09-08
EP2993231A3 (en) 2016-05-11
US9315770B2 (en) 2016-04-19
JP2016116517A (ja) 2016-06-30
EP2480661A1 (en) 2012-08-01
EP2993231A2 (en) 2016-03-09
SMT201800549T1 (it) 2018-11-09
WO2011036454A1 (en) 2011-03-31
ES2692811T3 (es) 2018-12-05

Similar Documents

Publication Publication Date Title
IN2012DN02401A (OSRAM)
CY1122174T1 (el) Βακτηριακο στελεχος ξενιστη που περιεχει ενα μεταλλαγμενο γονιδιο spr και ενα γονιδιο αγριου-τυπου tsp
GB201000591D0 (en) Bacterial hoist strain
EA024121B9 (ru) Композиции эндорибонуклеаз и способы их использования
NZ601241A (en) Improving activity of fe-s cluster requiring proteins
MY157111A (en) Recombinant microorganisms and methods of production thereof
NZ733709A (en) Clostridium histolyticum enzymes and methods for the use thereof
MY186219A (en) Production of proteins in glutamine-free cell culture media
MX352023B (es) Variantes de alfa-amilasa con estabilidad mejorada.
IN2015DN02771A (OSRAM)
NZ607627A (en) Mutated protoporphyrinogen ix oxidase (ppx) genes
UA112763C2 (uk) Алелі 1-дезокси-d-ксилулозо-5-фосфатсинтази, відповідальні за посилений біосинтез терпенів
MX2014000920A (es) Metodo para evaluar la integridad de la pared celular bacteriana.
MX349517B (es) Polipeptidos que tienen actividad de proteasa y polinucleotidos que codifican los mismos.
MX343699B (es) Construcción de expresión de adn.
SG195215A1 (en) Method of protein display
MX2013008252A (es) Firma de pronostico para la recurrencia de cancer colorrectal.
GB201021499D0 (en) Detection of quantative genetic differnces
EA201291159A1 (ru) Растения рода brassica с измененным строением
MX2012005380A (es) Biomarcadores secretores de proteina para expresion de una proteina de alta eficiencia.
MY193757A (en) Lantibiotic encoding nucleotide
MY192568A (en) Lantibiotic encoding nucleotide
MY194763A (en) Lantibiotic Encoding Nucleotide
RU2010140463A (ru) Бактериальный сенсор на основе штамма бактерий helicobacter pylori
UA44814U (ru) СПОСОБ СУПЕРСИНТЕЗА РЕКОМБИНАНТНОГО БЕЛКА rExhCD34 ПРОДУЦЕНТОМ ШТАММА Е.COLI BL21hCD34